Literature DB >> 11340611

Genetic determinants of basal cell carcinoma risk.

E Epstein1.   

Abstract

Basal cell carcinomas are can be induced by ionizing radiation, in particular in patients with the rare autosomal dominant basal cell nevus syndrome (BCNS). These patients also are prone to medulloblastomas, and curative ionizing radiation therapy for the latter is followed soon by the development of sheets of basal cell carcinomas in the overlying skin. Positional cloning of the gene mutant is BCNS patients has identified the hedgehog signaling pathway as crucial to the development of all basal cell carcinomas and presumably to this susceptibility to post-ionizing radiation carcinogenesis. Thus this pathway is a candidate for susceptibility to second, post-therapy cancers in the broader population. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11340611     DOI: 10.1002/mpo.1129

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  9 in total

Review 1.  Assessing cancer risks of low-dose radiation.

Authors:  Leon Mullenders; Mike Atkinson; Herwig Paretzke; Laure Sabatier; Simon Bouffler
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

Review 2.  The Hedgehog pathway: role in cell differentiation, polarity and proliferation.

Authors:  Yanfei Jia; Yunshan Wang; Jingwu Xie
Journal:  Arch Toxicol       Date:  2015-01-06       Impact factor: 5.153

Review 3.  Implications of hedgehog signaling antagonists for cancer therapy.

Authors:  Jingwu Xie
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-07       Impact factor: 3.848

4.  Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.

Authors:  Xiuwei Tang; Arianna L Kim; David J Feith; Anthony E Pegg; Justin Russo; Hong Zhang; Michelle Aszterbaum; Levy Kopelovich; Ervin H Epstein; David R Bickers; Mohammad Athar
Journal:  J Clin Invest       Date:  2004-03       Impact factor: 14.808

5.  The use of vismodegib to shrink keratocystic odontogenic tumors in patients with basal cell nevus syndrome.

Authors:  Mina S Ally; Jean Y Tang; Timmy Joseph; Bobbye Thompson; Joselyn Lindgren; Maria Acosta Raphael; Grace Ulerio; Anita M Chanana; Julian M Mackay-Wiggan; David R Bickers; Ervin H Epstein
Journal:  JAMA Dermatol       Date:  2014-05       Impact factor: 10.282

Review 6.  Clinical implications of hedgehog signaling pathway inhibitors.

Authors:  Hailan Liu; Dongsheng Gu; Jingwu Xie
Journal:  Chin J Cancer       Date:  2011-01

Review 7.  Non-Canonical Hh Signaling in Cancer-Current Understanding and Future Directions.

Authors:  Dongsheng Gu; Jingwu Xie
Journal:  Cancers (Basel)       Date:  2015-08-27       Impact factor: 6.639

Review 8.  Targeting hedgehog signaling in cancer: research and clinical developments.

Authors:  Jingwu Xie; Christopher M Bartels; Scott W Barton; Dongsheng Gu
Journal:  Onco Targets Ther       Date:  2013-10-10       Impact factor: 4.147

9.  Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.

Authors:  Sandeep C Chaudhary; Xiuwei Tang; Aadithya Arumugam; Changzhao Li; Ritesh K Srivastava; Zhiping Weng; Jianmin Xu; Xiao Zhang; Arianna L Kim; Kristopher McKay; Craig A Elmets; Levy Kopelovich; David R Bickers; Mohammad Athar
Journal:  Oncotarget       Date:  2015-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.